Thiard News@F4F

@newsen.bsky.social

6 days ago

Amazon Teamsters Achieve Landmark Union Recognition from NLRB in Major Victory In a groundbreaking ruling by the NLRB, Amazon Teamsters secure union recognition in a historic win that could change labor relations forever.

Amazon Teamsters Achieve Landmark Union Recognition from NLRB in Major Victory #United_States #Teamsters #Staten_Island #NLRB #Amazon_Labor_Union

Thiard News@F4F

@newsen.bsky.social

1 week ago

Acurx Pharmaceuticals Secures New Patent for Innovative DNA Polymerase IIIC Inhibitors Acurx Pharmaceuticals has been granted a new patent for DNA Polymerase IIIC inhibitors, enhancing its portfolio in antibiotic development and treatment for severe bacterial infections.

Acurx Pharmaceuticals Secures New Patent for Innovative DNA Polymerase IIIC Inhibitors #United_States #Staten_Island #Acurx_Pharmaceuticals #Antibiotic_Development #DNA_Polymerase_IIIC

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Understanding the Pitfalls of DIY Pest Control with Expert Insights from Chris David This article discusses common mistakes in DIY pest control, featuring insights from expert Chris David to help homeowners avoid costly infestations.

Understanding the Pitfalls of DIY Pest Control with Expert Insights from Chris David #United_States #Staten_Island #DIY_pest_control #Chris_David #Pest_Infestation

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Acurx Pharmaceuticals Unveils Year-End and Q4 Financial Update with Promising Developments Acurx Pharmaceuticals provides a comprehensive update on their financial performance for 2025, including innovative trials, strategic advancements in antibiotic development, and significant operational achievements.

Acurx Pharmaceuticals Unveils Year-End and Q4 Financial Update with Promising Developments #United_States #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals #Antibiotics

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Edelson Lechtzin LLP Investigates Data Breach Affecting UFCW Local 342 Members Edelson Lechtzin LLP is looking into claims involving a data breach at UFCW Local 342 that impacts over 56,000 individuals. Take action now!

Edelson Lechtzin LLP Investigates Data Breach Affecting UFCW Local 342 Members #United_States #Data_Breach #Edelson_Lechtzin #Staten_Island #UFCW_Local_342

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Breakthrough in CDI Treatment: Acurx Launches Innovative Ibezapolstat Trial Program Acurx Pharmaceuticals has unveiled a new clinical trial program for Ibezapolstat targeting recurrent CDI, aiming to transform treatment standards and efficacy.

Breakthrough in CDI Treatment: Acurx Launches Innovative Ibezapolstat Trial Program #United_States #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals #CDI_Treatment

Thiard News@F4F

@newsen.bsky.social

2 months ago

Acurx Pharmaceuticals Secures New Patent for Innovative Antibiotic Technology Acurx Pharmaceuticals has been awarded a new patent for its cutting-edge DNA Polymerase IIIC inhibitors, strengthening its IP in antibiotic development.

Acurx Pharmaceuticals Secures New Patent for Innovative Antibiotic Technology #United_States #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals #DNA_Polymerase_IIIC

Thiard News@F4F

@newsen.bsky.social

4 months ago

MetroPlusHealth Enhances Health Services on Staten Island with New Community Office Opening MetroPlusHealth is expanding healthcare access on Staten Island by opening its second community office, ensuring more residents receive affordable care.

MetroPlusHealth Enhances Health Services on Staten Island with New Community Office Opening #United_States #Staten_Island #Health_Services #MetroPlusHealth

Thiard News@F4F

@newsen.bsky.social

4 months ago

Annamarie Gulino Gentile Chairs Harvest Brunch Honoring Community Leader Olga Gaeta Annamarie Gulino Gentile will chair the CASC Harvest Brunch to honor Olga ‘Ollie’ Gaeta for her contributions to the senior community in Staten Island, N.Y.

Annamarie Gulino Gentile Chairs Harvest Brunch Honoring Community Leader Olga Gaeta #United_States #Staten_Island #Angiuli_Gentile #Olga_Gaeta #CASC

Thiard News@F4F

@newsen.bsky.social

4 months ago

Acurx Pharmaceuticals Shows Progress in Antibiotic Development in Q3 2025 Results Acurx Pharmaceuticals unveiled their third-quarter results, highlighting advancements in antibiotic development and patent approvals, while addressing financials.

Acurx Pharmaceuticals Shows Progress in Antibiotic Development in Q3 2025 Results #United_States #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals #Antibiotics

Thiard News@F4F

@newsen.bsky.social

4 months ago

Acurx Pharmaceuticals Publishes Landmark Study on New Antibiotic Mechanism Targeting Priority Pathogens Acurx Pharmaceuticals unveils groundbreaking research on DNA polymerase IIIC inhibitors, showcasing promising new antibiotics against severe bacterial infections.

Acurx Pharmaceuticals Publishes Landmark Study on New Antibiotic Mechanism Targeting Priority Pathogens #USA #Ibezapolstat #Acurx #Staten_Island #Antibiotics

Thiard News@F4F

@newsen.bsky.social

5 months ago

Acurx Pharmaceuticals Secures New Patent in Australia for Groundbreaking Antibiotic Technology Acurx Pharmaceuticals announces a new patent granted in Australia for DNA Polymerase IIIC inhibitors, enhancing its antibiotic R&D efforts.

Acurx Pharmaceuticals Secures New Patent in Australia for Groundbreaking Antibiotic Technology #Australia #Staten_Island #Acurx_Pharmaceuticals #DNA_Polymerase #antibiotic_research

Thiard News@F4F

@newsen.bsky.social

6 months ago

Acurx Pharmaceuticals Receives EMA Approval for Pediatric Use of Ibezapolstat Against C. difficile Acurx Pharmaceuticals has received a positive opinion from the EMA for its Pediatric Investigation Plan for ibezapolstat, a critical treatment for C. difficile infections in children.

Acurx Pharmaceuticals Receives EMA Approval for Pediatric Use of Ibezapolstat Against C. difficile #United_States #Ibezapolstat #C._difficile #Staten_Island #Acurx_Pharmaceuticals

Thiard News@F4F

@newsen.bsky.social

8 months ago

Acurx Pharmaceuticals Implements Reverse Stock Split to Boost Share Value Acurx Pharmaceuticals has announced a 1-for-20 reverse stock split, effective August 5, 2025, to enhance its stock value and maintain Nasdaq compliance.

Acurx Pharmaceuticals Implements Reverse Stock Split to Boost Share Value #USA #Shareholders #Stock_Split #Staten_Island #Acurx_Pharmaceuticals

Thiard News@F4F

@newsen.bsky.social

9 months ago

Acurx Pharmaceuticals Secures $2.67 Million by Exercising Warrants Acurx Pharmaceuticals has announced a successful warrant inducement agreement, generating $2.67 million in proceeds in a bid to bolster its antibiotic development efforts.

Acurx Pharmaceuticals Secures $2.67 Million by Exercising Warrants #United_States #biopharmaceuticals #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals

Thiard News@F4F

@newsen.bsky.social

9 months ago

Acurx's Ibezapolstat Shows Promising Results in Latest Clinical Trial for C. Difficile Infection Treatment Acurx Pharmaceuticals announces positive findings for Ibezapolstat, its innovative antibiotic for treating C. difficile infection, from a Phase 2b clinical trial. This promising data underlines the drug's potential.

Acurx's Ibezapolstat Shows Promising Results in Latest Clinical Trial for C. Difficile Infection Treatment #USA #Ibezapolstat #C._difficile #Staten_Island #Acurx_Pharmaceuticals

Thiard News@F4F

@newsen.bsky.social

10 months ago

Honda of Staten Island Partners with Tunnel to Towers Foundation to Support Local Heroes Honda of Staten Island proudly announces its partnership with the Tunnel to Towers Foundation, pledging support for veterans and first responders through vehicle sales.

Honda of Staten Island Partners with Tunnel to Towers Foundation to Support Local Heroes #USA #veterans_support #Staten_Island #Tunnel_to_Towers #Honda_Staten_Island

Thiard News@F4F

@newsen.bsky.social

10 months ago

Acurx Pharmaceuticals Reports Strong Q1 2025 Results and Key Business Updates Acurx Pharmaceuticals delivers an encouraging financial report for Q1 2025, highlighting advancements in antibiotic development and strategic partnerships.

Acurx Pharmaceuticals Reports Strong Q1 2025 Results and Key Business Updates #USA #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals #Antibiotic_Development

Thiard News@F4F

@newsen.bsky.social

1 year ago

Verdek Unveils State-of-the-Art Electric Vehicle Charging Facility in Staten Island Verdek LLC announces the completion of a cutting-edge electric vehicle charging facility in Staten Island, setting new standards for public transit infrastructure.

Verdek Unveils State-of-the-Art Electric Vehicle Charging Facility in Staten Island #United_States #EV_Charging #Staten_Island #Verdek

Thiard News@F4F

@newsen.bsky.social

1 year ago

Acurx Pharmaceuticals Unveils Encouraging Fourth Quarter and Year-End Results for 2024 Acurx Pharmaceuticals shares positive results from Q4 2024 and provides updates on its innovative antibiotic, Ibezapolstat's efficacy against CDI.

Acurx Pharmaceuticals Unveils Encouraging Fourth Quarter and Year-End Results for 2024 #United_States #Ibezapolstat #C._difficile #Staten_Island #Acurx_Pharmaceuticals

Thiard News@F4F

@newsen.bsky.social

1 year ago

Acurx Pharmaceuticals Announces $1.1 Million Direct Offering for New Antibiotics Development Acurx Pharmaceuticals has unveiled a $1.1 million registered direct offering to support the development of its groundbreaking antibiotics, aimed at combating challenging bacterial infections.

Acurx Pharmaceuticals Announces $1.1 Million Direct Offering for New Antibiotics Development #United_States #stock_offering #Staten_Island #Acurx_Pharmaceuticals #Antibiotics_Development

Thiard News@F4F

@newsen.bsky.social

1 year ago

Acurx's Innovative Research Differentiates Ibezapolstat's Impact on Gut Microbiome Acurx Pharmaceuticals published groundbreaking results showing how Ibezapolstat uniquely affects the gut microbiome, distinguishing it from other antibiotics used for CDI.

Acurx's Innovative Research Differentiates Ibezapolstat's Impact on Gut Microbiome #USA #Ibezapolstat #Acurx #Staten_Island #CDI

Thiard News@F4F

@newsen.bsky.social

1 year ago

Acurx Pharmaceuticals Revels in Positive In-Silico Findings on Ibezapolstat's Efficacy for CDI Treatment Acurx Pharmaceuticals has unveiled promising findings from their in-silico study on ibezapolstat, showcasing its potential to restore gut microbiome in CDI treatment.

Acurx Pharmaceuticals Revels in Positive In-Silico Findings on Ibezapolstat's Efficacy for CDI Treatment #USA #Ibezapolstat #Acurx #Staten_Island #CDI

Thiard News@F4F

@newsen.bsky.social

1 year ago

Acurx Pharmaceuticals Expands Patent Portfolio in Japan for Antibiotic Development Acurx Pharmaceuticals has secured a new patent in Japan for DNA Polymerase IIIC inhibitors, advancing its innovative antibiotics targeting serious bacterial infections.

Acurx Pharmaceuticals Expands Patent Portfolio in Japan for Antibiotic Development #Japan #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals #DNA_Polymerase_IIIC

Thiard News@F4F

@newsen.bsky.social

1 year ago

Acurx Pharmaceuticals Secures $2.5 Million in Direct Stock Offering Amid Development of New Antibiotic Class Acurx Pharmaceuticals has successfully closed a $2.5 million direct offering of its common stock, designed to fund the development of innovative antibiotics targeting resistant bacterial infections.

Acurx Pharmaceuticals Secures $2.5 Million in Direct Stock Offering Amid Development of New Antibiotic Class #United_States #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals #Antibiotic_Development

Thiard News@F4F

@newsen.bsky.social

1 year ago

Acurx Pharmaceuticals Executes $2.5 Million Direct Stock Offering to Advance Antibiotic Development Acurx Pharmaceuticals announced a direct stock offering aimed at raising $2.5 million to support its development of innovative antibiotics targeting resistant bacterial infections.

Acurx Pharmaceuticals Executes $2.5 Million Direct Stock Offering to Advance Antibiotic Development #United_States #Ibezapolstat #Staten_Island #Acurx_Pharmaceuticals #Antibiotics

Thiard News@F4F

@newsen.bsky.social

1 year ago

Acurx Pharmaceuticals Steps Forward with Ibezapolstat Phase 3 Trials for C. Difficile Infections Following EMA Guidance Acurx Pharmaceuticals has received positive feedback from the EMA, paving the way for Phase 3 trials of Ibezapolstat to combat C. difficile infections.

Acurx Pharmaceuticals Steps Forward with Ibezapolstat Phase 3 Trials for C. Difficile Infections Following EMA Guidance #United_States #Ibezapolstat #C._difficile #Staten_Island #Acurx_Pharmaceuticals

Thiard News@F4F

@newsen.bsky.social

1 year ago

Amazon Teamsters at JFK8 Join Historical Strike Against Corporate Giants Amazon Teamsters at JFK8 in Staten Island join a historic strike against the corporation, demanding respect and fair wages amidst challenging conditions.

Amazon Teamsters at JFK8 Join Historical Strike Against Corporate Giants #United_States #Staten_Island #JFK8 #Labor_Union #Amazon_Teamsters

Thiard News@F4F

@newsen.bsky.social

1 year ago

Epicured Launches Fair Start Initiative with Health Partners to Improve Nutrition and Accessibility Epicured joins hands with Staten Island PPS and Columbia University's Mailman School to enhance health equity through improved nutrition access.

Epicured Launches Fair Start Initiative with Health Partners to Improve Nutrition and Accessibility #United_States #Staten_Island #Epicured #Fair_Start

Thiard News@F4F

@newsen.bsky.social

1 year ago

Acurx Pharmaceuticals Advances Ibezapolstat to Phase 3 Trials for C. Difficile Infections Following Regulatory Endorsements Acurx Pharmaceuticals is gearing up for international Phase 3 clinical trials for its antibiotic Ibezapolstat, targeting C. difficile infections, following positive feedback from the FDA and EMA.

Acurx Pharmaceuticals Advances Ibezapolstat to Phase 3 Trials for C. Difficile Infections Following Regulatory Endorsements #USA #Ibezapolstat #Acurx #C._difficile #Staten_Island